AHA participated today in a stakeholder listening session hosted by Centers for Medicare & Medicaid Services Administrator Seema Verma to formally launch the agency’s regulatory relief effort. AHA President and CEO Rick Pollack thanked the agency for recent actions to reduce the regulatory burden on health care providers, noting a new AHA report that found non-clinical regulatory requirements cost providers nearly $39 billion a year and divert clinicians from patient care. To further reduce this regulatory burden, he encouraged the agency to modernize “fraud and abuse rules” to allow hospitals and doctors to collaborate on additional innovative care models; align quality reporting across all its programs and focus on “measures that matter”; ensure hospitals are not penalized by audits that use unfair sampling methods to determine Medicare repayments; and expand and make more flexible Medicare coverage of telehealth services, among other actions. For more on how the scope and volume of regulatory requirements are diverting resources from the patient-centered mission of health systems, hospitals and post-acute care providers, visit www.aha.org/regrelief.

Related News Articles

Headline
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026.…